What Is Ipamorelin?
$47.25 · COA do lote publicado · Água BAC grátis + frete grátis nos EUA · Despacho no mesmo dia antes das 14h ET · APENAS PARA USO EM PESQUISA
Comprar peptídeo Ipamorelin 10mgResposta Rapida
Visao Geral da Pesquisa Ipamorelin (NNC 26-0161) is a synthetic pentapeptide hormonio do crescimento secretagogue with a sequencia Aib-His-D-2-Nal-D-Phe-Lys-NH₂, developed by Novo Nordisk no(a) mid-1990s by systematic modification of GHRP-1. It acts como um(a) highly selective agonist do(a) GHS-R1a ...
Ipamorelin — Quick Facts
| Molecular formula | C38H49N9O5 |
|---|---|
| Molecular weight | 711.9 g/mol |
| InChI key | NEHWBYHLYZGBNO-BVEPWEIPSA-N |
| PubChem CID | 9831659 |
| Storage | Liofilizado: -18°C to -20°C (estável vários anos); proteja da luz. |
| Cited references | 21 |
Chemical identity from PubChem CID 9831659. For research use only.
Visao Geral da Pesquisa
Ipamorelin (NNC 26-0161) is a synthetic pentapeptide hormonio do crescimento secretagogue with a sequencia Aib-His-D-2-Nal-D-Phe-Lys-NH₂, developed by Novo Nordisk no(a) mid-1990s by systematic modification of GHRP-1. It acts como um(a) highly selective agonist do(a) GHS-R1a receptor (ghrelin receptor), stimulating potent, pulsatile hormonio do crescimento release sem affecting ACTH, cortisol, FSH, LH, TSH, or prolactin — even at 200× o efeitoive dose.[1][2]
Ipamorelin research spans 8+ indication categories incluindo selective GH secretion, postoperative ileus, bone growth, composicao corporal, secrecao de insulina, pain modulacao, and cancer caquexia. A Phase II ensaio clinico for POI (n=114, NCT00672074) failed to reach significancia estatistica, and desenvolvimento clinico was discontinued.[6][4]
Key distinguishing features include: (1) first selective GHS with GHRH-like specificity, (2) no somatotroph dessensibilizacao upon cronico(a) administration, (3) linear pharmacokinetics in humans (T½ ~2h), and (4) GH-independent adipogenic effects.[1][9]
“Resumo da Pesquisa Pre-clinica Key Preclinical Studies EstudoModeloPrincipais AchadosRef Raun et al.”
Referencias
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the primeiro(a) selective hormonio do crescimento secretagogue. European Journal of Endocrinology. 1998;139(5):552-561.
- Gobburu JVS, Agersø H, Jusko WJ, Ynddal L. Pharmaceutical Research. 1999;16(9):1412-1416.
- Johansen PB, Nowak J, Skjaerbaek C, et al. Ipamorelin, a novo(a) growth-hormone-releasing peptide, induz longitudinal bone growth in rats. Growth Hormone & IGF Research. 1999;9(2):106-113.
- Venkova K, Mann W, Nelson R, Greenwood-Van Meerveld B. JPET. 2009;329(3):1110-1116.
- Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C. Journal of Experimental Pharmacology. 2012;4:149-155.
- Beck DE, Sweeney WB, McCarter MD. Int J Colorectal Dis. 2014;29(12):1527-1534.
- Jiménez-Reina L, Cañete R, de la Torre MJ, Bernal G. European Journal of Anatomy. 2002;6(1):37-45.
- Svensson J, Lall S, Dickson SL, Jansson JO. Journal of Endocrinology. 2000;165:569-577.
- Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent estimulacao of adiposity by GH secretagogues. BBRC. 2001;280(1):132-138.
- Adeghate E, Ponery AS. Mechanism of ipamorelin-evoked insulin release do(a) pancreas of normal and ratos diabeticos. Neuro Endocrinology Letters. 2004;25(6):403-406.
- Johansen PB, Hansen KT, Andersen JV, Johansen NL. Xenobiotica. 1998;28(11):1083-1092.
- Andersen NB, Malmlöf K, Johansen PB, Oxlund H. Growth Hormone & IGF Research. 2001;11(5):266-272.
- Hansen TK, Ankersen M, Raun K, Hansen BS. Highly Potent Growth Hormone Secretagogues: Hybrids of NN703 and Ipamorelin. Bioorganic & Medicinal Chemistry Letters. 2001;11(14):1915-1918.
- Lu Z, Ngan MP, Liu JYH, Rudd JA. Physiology & Behavior. 2024.
- Sinha DK, Balasubramanian A, Tatem AJ, et al. Translational Andrology and Urology. 2020;9(Suppl 2):S149-S159.
- Thøgersen H, Johansen NL, Lau J, et al. A New Series of Highly Potent Growth Hormone-Releasing Peptides Derived from Ipamorelin. Journal of Medicinal Chemistry. 1998;41.
- Mohammadi E, Bhatt V, Bhatt AB, Pietra C, Greenwood-Van Meerveld B. Ipamorelin atenua visceral and somatic nociception through periferico(a) ghrelin receptor mechanisms. 2020.
- U.S. Food & Drug Administration. FDA Evaluation of Ipamorelin-Related Substancia Farmaceutica a Granels. FDA Pharmacy Compounding Advisory Committee. 2024.
- World Anti-Doping Agency. WADA Lista de Substancias Proibidas — S2: Hormonios Peptidicos, Fatores de Crescimento, Substancias Relacionadas e Mimeticos. 2024.
- Polvino WJ. US Patent 8,039,456 B2.
- Thøger Nielsen K, et al. Validated screening method for GH-releasing peptides using UHPLC-HRMS on dried blood spots. Drug Testing and Analysis. 2021.
Perguntas de Pesquisa Relacionadas
Related research
Browse all research guides in the Peptide Research Library →Deseja a revisao completa da pesquisa?
Comprar peptídeo Ipamorelin 10mg→APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.
